Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...

The Manipal Academy of Higher Education (MAHE), a pioneer in technology-driven research and education, participated in the ...

The support is designed to speed development of well-matched H5N1 vaccines and pave the way for vaccines against other ...

DALLAS - Spectral AI, Inc. (NASDAQ:MDAI), a Dallas-based company specializing in medical diagnostics with its AI-driven DeepView® System, has announced its expected financial outcomes for the year ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density microarray patch (HD-MAP) vaccination platform, today announced that CEPI, the Coalition for Epidemic Preparedness ...

The U.S. Department of Health and Human Services (HHS) announced plans to invest $211 million in the Rapid Response ...

A new paper led by Professor Imanuel Lerman of UC San Diego provides a review of the field of bioelectronic medicine and the most promising opportunities for life-changing new therapies and ...

Two contentious issues that may never be resolved are disagreement between India and Sri Lanka over granting police and land ...

By Dr. Siri Galhenage [email protected] ‘They are shallow animals, having always employed their minds about Body and Gut, they imagine that in the whole system of things there is nothing but Gut ...

VelocityTX’s vision for its campus and for a larger innovation district in East San Antonio predates the pandemic. More recent events, including the planned merger of UTSA and UT Health San Antonio, ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...